Deutsche Gesellschaft für Regenerative Medizin e. V.Deutsche Gesellschaft für Regenerative Medizin e. V.

About

RegMedInvest is a new product created by the German Society for Regenerative Medicine (GRM). It is an annual Investors Conference dedicated to the new field of regenerative medicine.

It is directed at strategic and financial investors interested to invest in regenerative medicine projects. The audience includes research based pharmaceutical, biotech, health care and life science companies as well as venture capital, seed capital, private equity and institutional finance investors. Technologies and projects presented at RegMedInvest originate from the network already established by GRM. This conference is carried out in a more personal setting to allow meaningful in depth dialog between the participants.